Clinical Trial: A Study on the Safety and Efficacy of TQB3473 Tablets in the Treatment of Persistent or Chronic Primary Immune Thrombocytopenia (ITP) in Adults

U.S., July 25 -- ClinicalTrials.gov registry received information related to the study (NCT07083739) titled 'A Study on the Safety and Efficacy of TQB3473 Tablets in the Treatment of Persistent or Chronic Primary Immune Thrombocytopenia (ITP) in Adults' on July 16.

Brief Summary: This study is an extension of the TQB3473-III-01 study, aimed at evaluating the safety and efficacy of TQB3473 tablets in adult patients with persistent or chronic ITP who have received at least one ITP standard treatment that is ineffective or has recurred after treatment. This is a single arm, open label, multi cohort, multi center Phase II clinical study.

Study Start Date: Aug., 2025

Study Type: INTERVENTIONAL

Condition: Primary Immune Thrombocytopenia

Int...